BRD4 and cervical carcinoma: To investigate the cellular uptake of ARV@PDSA and achieving proteolysis of BRD4,[22] we first labeled PDSA nanoparticles with Nile Red and tested them in human cervical cancer cells (HeLa) and murine melanoma cells (B16F10).